Congress Finishes Spending Bill

Federal science agencies get some relief from the harsh cuts to their 2013 budgets instituted by the recent sequester.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, DORIThe effects of the US government’s 5 percent, across-the-board cuts to discretionary funding have been softened somewhat by a temporary spending bill passed by Congress last week (March 20). For key science agencies, such as the National Science Foundation (NSF), NASA, and the National Institutes of Health (NIH), there is some consolation in the “Consolidated and Further Continuing Appropriations Act,” which funds the government through September 30—but concerns remain.

The NSF, which funds life science research as well as work in other fields, will see its $7 billion budget slashed 2.9 percent instead of the sequester’s 5 percent, thanks to the work of Senator Barbara Mikulski (D-MD), chair of the Senate Appropriations Committee. The new bill also allows the NSF to cut the $356 million dictated by the sequester from a broader base of programs within its mandate. According to ScienceInsider, this means that the agency will eliminate fewer new grants than the 1,000 that it had initially projected.

The NIH’s budget got a small increase of $67 million in the deal struck last week, but that did little to ease the burden of the $1.5 billion cut that sequestration put into effect starting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies